The epidemiology of glucocorticoid-associated adverse events

Pisu, 2005, The cost of glucocorticoid-associated adverse events in rheumatoid arthritis, Rheumatology (Oxford), 44, 781, 10.1093/rheumatology/keh594

van Staa, 2000, Use of oral corticosteroids in the United Kingdom, QJM, 93, 105, 10.1093/qjmed/93.2.105

Da Silva, 2006, Safety of low dose glucocorticoid treatment in rheumatoid arthritis: published evidence and prospective trial data, Ann Rheum Dis, 65, 285, 10.1136/ard.2005.038638

Steinbuch, 2004, Oral glucocorticoid use is associated with an increased risk of fracture, Osteoporos Int, 15, 323, 10.1007/s00198-003-1548-3

Wolfe, 2006, Treatment for rheumatoid arthritis and the risk of hospitalization for pneumonia: associations with prednisone, disease-modifying antirheumatic drugs, and antitumor necrosis factor therapy, Arthritis Rheum, 54, 628, 10.1002/art.21568

Doran, 2002, Predictors of infection in rheumatoid arthritis, Arthritis Rheum, 46, 2294, 10.1002/art.10529

Gaffo, 2006, Treatment of rheumatoid arthritis, Am J Health Syst Pharm, 63, 2451, 10.2146/ajhp050514

Van Staa, 2000, Use of oral corticosteroids and risk of fractures, J Bone Miner Res, 15, 993, 10.1359/jbmr.2000.15.6.993

Angeli, 2006, High prevalence of asymptomatic vertebral fractures in postmenopausal women receiving chronic glucocorticoid therapy: a cross-sectional outpatient study, Bone, 39, 253, 10.1016/j.bone.2006.02.005

Curtis, 2006, Population-based assessment of adverse events associated with long-term glucocorticoid use, Arthritis Rheum, 55, 420, 10.1002/art.21984

Fardet, 2007, Corticosteroid-induced clinical adverse events: frequency, risk factors and patient's opinion, Br J Dermatol, 157, 142, 10.1111/j.1365-2133.2007.07950.x

van Staa, 2002, The epidemiology of corticosteroid-induced osteoporosis: a meta-analysis, Osteoporos Int, 13, 777, 10.1007/s001980200108

Gudbjornsson, 2002, Prevalence of long term steroid treatment and the frequency of decision making to prevent steroid induced osteoporosis in daily clinical practice, Ann Rheum Dis, 61, 32, 10.1136/ard.61.1.32

Kanis, 2004, A meta-analysis of prior corticosteroid use and fracture risk, J Bone Miner Res, 19, 893, 10.1359/JBMR.040134

Natsui, 2006, High-dose glucocorticoid treatment induces rapid loss of trabecular bone mineral density and lean body mass, Osteoporos Int, 17, 105, 10.1007/s00198-005-1923-3

Summey, 2006, Glucocorticoid-induced bone loss in dermatologic patients: an update, Arch Dermatol, 142, 82, 10.1001/archderm.142.1.82

Shah, 2006, Prednisone-induced osteoporosis: an overlooked and undertreated adverse effect, J Am Osteopath Assoc, 106, 653

Saag, 2006, Trends in prevention of glucocorticoid-induced osteoporosis, J Rheumatol, 33, 1651

Saag, 2006, Trends in prevention of glucocorticoid-induced osteoporosis, J Rheumatol, 33, 1651

Mazziotti, 2006, Glucocorticoid-induced osteoporosis: an update, Trends Endocrinol Metab, 17, 144, 10.1016/j.tem.2006.03.009

Van Staa, 2003, Bone density threshold and other predictors of vertebral fracture in patients receiving oral glucocorticoid therapy, Arthritis Rheum, 48, 3224, 10.1002/art.11283

van Staa, 2006, The pathogenesis, epidemiology and management of glucocorticoid-induced osteoporosis, Calcif Tissue Int, 79, 129, 10.1007/s00223-006-0019-1

De Vries, 2007, Fracture risk with intermittent high-dose oral glucocorticoid therapy, Arthritis Rheum, 56, 208, 10.1002/art.22294

Lee, 2006, Disease damage and low bone mineral density: an analysis of women with systemic lupus erythematosus ever and never receiving corticosteroids, Rheumatology (Oxford), 45, 53, 10.1093/rheumatology/kei079

Popp, 2006, Glucocorticosteroid-induced spinal osteoporosis: scientific update on pathophysiology and treatment, Eur Spine J, 15, 1035, 10.1007/s00586-005-0056-x

Franklin, 2007, Risk and predictors of infection leading to hospitalisation in a large primary-care-derived cohort of patients with inflammatory polyarthritis, Ann Rheum Dis, 66, 308, 10.1136/ard.2006.057265

Schneeweiss, 2007, Antitumor necrosis factor alpha therapy and the risk of serious bacterial infections in elderly patients with rheumatoid arthritis, Arthritis Rheum, 56, 1754, 10.1002/art.22600

Lichtenstein, 2006, Serious infections and mortality in association with therapies for Crohn's disease: TREAT registry, Clin Gastroenterol Hepatol, 4, 621, 10.1016/j.cgh.2006.03.002

Jick, 2006, Glucocorticoid use, other associated factors, and the risk of tuberculosis, Arthritis Rheum, 55, 19, 10.1002/art.21705

Wei, 2004, Taking glucocorticoids by prescription is associated with subsequent cardiovascular disease, Ann Intern Med, 141, 764, 10.7326/0003-4819-141-10-200411160-00007

Souverein, 2004, Use of oral glucocorticoids and risk of cardiovascular and cerebrovascular disease in a population based case-control study, Heart, 90, 859, 10.1136/hrt.2003.020180

Maradit Kremers, 2007, Glucocorticoids and cardiovascular and cerebrovascular events in polymyalgia rheumatica, Arthritis Rheum, 57, 279, 10.1002/art.22548

Chrousos, 2007, Glucocorticoid action networks and complex psychiatric and/or somatic disorders, Stress, 10, 213, 10.1080/10253890701292119

Hibberd, 2000, Glucocorticoids and the ageing hippocampus, J Anat, 197, 553, 10.1046/j.1469-7580.2000.19740553.x

Fusar-Poli, 2007, Depression after lung transplantation: causes and treatment, Lung, 185, 55, 10.1007/s00408-006-0093-1

Brown, 2006, Effect of two prednisone exposures on mood and declarative memory, Neurobiol Learn Mem, 86, 28, 10.1016/j.nlm.2005.12.009

Steinberg, 2006, Efficacy and safety of corticosteroids for persistent acute respiratory distress syndrome, N Engl J Med, 354, 1671, 10.1056/NEJMoa051693

Lee, 2006, Steroid myopathy in patients with acute graft-versus-host disease treated with high-dose steroid therapy, Bone Marrow Transplant, 38, 299, 10.1038/sj.bmt.1705435

Uchida, 2006, Preoperative steroid-related complications in Japanese pediatric patients with ulcerative colitis, Dis Colon Rectum, 49, 74, 10.1007/s10350-005-0213-7

van Staa, 2003, Children and the risk of fractures caused by oral corticosteroids, J Bone Miner Res, 18, 913, 10.1359/jbmr.2003.18.5.913

King, 2007, Orthopedic outcomes of long-term daily corticosteroid treatment in Duchenne muscular dystrophy, Neurology, 68, 1607, 10.1212/01.wnl.0000260974.41514.83

Leonard, 2007, Glucocorticoid-induced osteoporosis in children: impact of the underlying disease, Pediatrics, 119, S166, 10.1542/peds.2006-2023J

Walther, 2006, Osteoporosis in pediatric patients suffering from chronic inflammatory bowel disease with and without steroid treatment, J Pediatr Gastroenterol Nutr, 43, 42, 10.1097/01.mpg.0000228105.91240.80

Seckl, 2007, Mechanisms of disease: glucocorticoids, their placental metabolism and fetal ‘programming’ of adult pathophysiology, Nat Clin Pract Endocrinol Metab, 3, 479, 10.1038/ncpendmet0515

Crowther, 2006, Neonatal respiratory distress syndrome after repeat exposure to antenatal corticosteroids: a randomised controlled trial, Lancet, 367, 1913, 10.1016/S0140-6736(06)68846-6

Hoes, 2007, EULAR evidence based recommendations on the management of systemic glucocorticoid therapy in rheumatic diseases, Ann Rheum Dis, 66, 1560, 10.1136/ard.2007.072157